Global Low Molecular Weight Heparin Market Analysis and Forecast 2024-2030

Global Low Molecular Weight Heparin Market Analysis and Forecast 2024-2030


Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.

Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.

According to APO Research, The global Low Molecular Weight Heparin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Global Low Molecular Weight Heparin main players are Aspen, Sanofi-aventis, CSBIO, Dongying Tiandong Pharmaceutical, Techdow, etc. Top five companies hold a share above 55%. Europe is the largest market, with a share about 35%.

In terms of production side, this report researches the Low Molecular Weight Heparin production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Low Molecular Weight Heparin by region (region level and country level), by Company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

This report presents an overview of global market for Low Molecular Weight Heparin, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Low Molecular Weight Heparin, also provides the consumption of main regions and countries. Of the upcoming market potential for Low Molecular Weight Heparin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Low Molecular Weight Heparin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Low Molecular Weight Heparin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Low Molecular Weight Heparin sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow and Yantai Dongcheng Pharmaceutical Group, etc.

Low Molecular Weight Heparin segment by Company

Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

Low Molecular Weight Heparin segment by Type

Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine

Low Molecular Weight Heparin segment by Application

Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others

Low Molecular Weight Heparin segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Low Molecular Weight Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Low Molecular Weight Heparin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Low Molecular Weight Heparin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Low Molecular Weight Heparin production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of Low Molecular Weight Heparin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of Low Molecular Weight Heparin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Low Molecular Weight Heparin sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: Middle East, Africa, Latin America by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.
Chapter 15: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Low Molecular Weight Heparin Market by Type
1.2.1 Global Low Molecular Weight Heparin Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Enoxaparin
1.2.3 Dalteparin
1.2.4 Tinzaparin
1.2.5 Fraxiparine
1.3 Low Molecular Weight Heparin Market by Application
1.3.1 Global Low Molecular Weight Heparin Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Low Molecular Weight Heparin Market Dynamics
2.1 Low Molecular Weight Heparin Industry Trends
2.2 Low Molecular Weight Heparin Industry Drivers
2.3 Low Molecular Weight Heparin Industry Opportunities and Challenges
2.4 Low Molecular Weight Heparin Industry Restraints
3 Global Low Molecular Weight Heparin Production Overview
3.1 Global Low Molecular Weight Heparin Production Capacity (2019-2030)
3.2 Global Low Molecular Weight Heparin Production by Region: 2019 VS 2023 VS 2030
3.3 Global Low Molecular Weight Heparin Production by Region
3.3.1 Global Low Molecular Weight Heparin Production by Region (2019-2024)
3.3.2 Global Low Molecular Weight Heparin Production by Region (2025-2030)
3.3.3 Global Low Molecular Weight Heparin Production Market Share by Region (2019-2030)
3.4 North America
3.5 Europe
3.6 China
4 Global Market Growth Prospects
4.1 Global Low Molecular Weight Heparin Revenue Estimates and Forecasts (2019-2030)
4.2 Global Low Molecular Weight Heparin Revenue by Region
4.2.1 Global Low Molecular Weight Heparin Revenue by Region: 2019 VS 2023 VS 2030
4.2.2 Global Low Molecular Weight Heparin Revenue by Region (2019-2024)
4.2.3 Global Low Molecular Weight Heparin Revenue by Region (2025-2030)
4.2.4 Global Low Molecular Weight Heparin Revenue Market Share by Region (2019-2030)
4.3 Global Low Molecular Weight Heparin Sales Estimates and Forecasts 2019-2030
4.4 Global Low Molecular Weight Heparin Sales by Region
4.4.1 Global Low Molecular Weight Heparin Sales by Region: 2019 VS 2023 VS 2030
4.4.2 Global Low Molecular Weight Heparin Sales by Region (2019-2024)
4.4.3 Global Low Molecular Weight Heparin Sales by Region (2025-2030)
4.4.4 Global Low Molecular Weight Heparin Sales Market Share by Region (2019-2030)
4.5 US & Canada
4.6 Europe
4.7 China
4.8 Asia (Excluding China)
4.9 Middle East, Africa and Latin America
5 Market Competitive Landscape by Manufacturers
5.1 Global Low Molecular Weight Heparin Revenue by Manufacturers
5.1.1 Global Low Molecular Weight Heparin Revenue by Manufacturers (2019-2024)
5.1.2 Global Low Molecular Weight Heparin Revenue Market Share by Manufacturers (2019-2024)
5.1.3 Global Low Molecular Weight Heparin Manufacturers Revenue Share Top 10 and Top 5 in 2023
5.2 Global Low Molecular Weight Heparin Sales by Manufacturers
5.2.1 Global Low Molecular Weight Heparin Sales by Manufacturers (2019-2024)
5.2.2 Global Low Molecular Weight Heparin Sales Market Share by Manufacturers (2019-2024)
5.2.3 Global Low Molecular Weight Heparin Manufacturers Sales Share Top 10 and Top 5 in 2023
5.3 Global Low Molecular Weight Heparin Sales Price by Manufacturers (2019-2024)
5.4 Global Low Molecular Weight Heparin Key Manufacturers Ranking, 2022 VS 2023 VS 2024
5.5 Global Low Molecular Weight Heparin Key Manufacturers Manufacturing Sites & Headquarters
5.6 Global Low Molecular Weight Heparin Manufacturers, Product Type & Application
5.7 Global Low Molecular Weight Heparin Manufacturers Commercialization Time
5.8 Market Competitive Analysis
5.8.1 Global Low Molecular Weight Heparin Market CR5 and HHI
5.8.2 2023 Low Molecular Weight Heparin Tier 1, Tier 2, and Tier 3
6 Low Molecular Weight Heparin Market by Type
6.1 Global Low Molecular Weight Heparin Revenue by Type
6.1.1 Global Low Molecular Weight Heparin Revenue by Type (2019 VS 2023 VS 2030)
6.1.2 Global Low Molecular Weight Heparin Revenue by Type (2019-2030) & (US$ Million)
6.1.3 Global Low Molecular Weight Heparin Revenue Market Share by Type (2019-2030)
6.2 Global Low Molecular Weight Heparin Sales by Type
6.2.1 Global Low Molecular Weight Heparin Sales by Type (2019 VS 2023 VS 2030)
6.2.2 Global Low Molecular Weight Heparin Sales by Type (2019-2030) & (MT)
6.2.3 Global Low Molecular Weight Heparin Sales Market Share by Type (2019-2030)
6.3 Global Low Molecular Weight Heparin Price by Type
7 Low Molecular Weight Heparin Market by Application
7.1 Global Low Molecular Weight Heparin Revenue by Application
7.1.1 Global Low Molecular Weight Heparin Revenue by Application (2019 VS 2023 VS 2030)
7.1.2 Global Low Molecular Weight Heparin Revenue by Application (2019-2030) & (US$ Million)
7.1.3 Global Low Molecular Weight Heparin Revenue Market Share by Application (2019-2030)
7.2 Global Low Molecular Weight Heparin Sales by Application
7.2.1 Global Low Molecular Weight Heparin Sales by Application (2019 VS 2023 VS 2030)
7.2.2 Global Low Molecular Weight Heparin Sales by Application (2019-2030) & (MT)
7.2.3 Global Low Molecular Weight Heparin Sales Market Share by Application (2019-2030)
7.3 Global Low Molecular Weight Heparin Price by Application
8 Company Profiles
8.1 Aspen
8.1.1 Aspen Comapny Information
8.1.2 Aspen Business Overview
8.1.3 Aspen Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.1.4 Aspen Low Molecular Weight Heparin Product Portfolio
8.1.5 Aspen Recent Developments
8.2 Sanofi-aventis
8.2.1 Sanofi-aventis Comapny Information
8.2.2 Sanofi-aventis Business Overview
8.2.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.2.4 Sanofi-aventis Low Molecular Weight Heparin Product Portfolio
8.2.5 Sanofi-aventis Recent Developments
8.3 Pfizer
8.3.1 Pfizer Comapny Information
8.3.2 Pfizer Business Overview
8.3.3 Pfizer Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.3.4 Pfizer Low Molecular Weight Heparin Product Portfolio
8.3.5 Pfizer Recent Developments
8.4 Opocrin
8.4.1 Opocrin Comapny Information
8.4.2 Opocrin Business Overview
8.4.3 Opocrin Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.4.4 Opocrin Low Molecular Weight Heparin Product Portfolio
8.4.5 Opocrin Recent Developments
8.5 CSBIO
8.5.1 CSBIO Comapny Information
8.5.2 CSBIO Business Overview
8.5.3 CSBIO Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.5.4 CSBIO Low Molecular Weight Heparin Product Portfolio
8.5.5 CSBIO Recent Developments
8.6 Dongying Tiandong Pharmaceutical
8.6.1 Dongying Tiandong Pharmaceutical Comapny Information
8.6.2 Dongying Tiandong Pharmaceutical Business Overview
8.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product Portfolio
8.6.5 Dongying Tiandong Pharmaceutical Recent Developments
8.7 Changzhou Qianhong Bio-pharma
8.7.1 Changzhou Qianhong Bio-pharma Comapny Information
8.7.2 Changzhou Qianhong Bio-pharma Business Overview
8.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product Portfolio
8.7.5 Changzhou Qianhong Bio-pharma Recent Developments
8.8 Techdow
8.8.1 Techdow Comapny Information
8.8.2 Techdow Business Overview
8.8.3 Techdow Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.8.4 Techdow Low Molecular Weight Heparin Product Portfolio
8.8.5 Techdow Recent Developments
8.9 Yantai Dongcheng Pharmaceutical Group
8.9.1 Yantai Dongcheng Pharmaceutical Group Comapny Information
8.9.2 Yantai Dongcheng Pharmaceutical Group Business Overview
8.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2019-2024)
8.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product Portfolio
8.9.5 Yantai Dongcheng Pharmaceutical Group Recent Developments
9 North America
9.1 North America Low Molecular Weight Heparin Market Size by Type
9.1.1 North America Low Molecular Weight Heparin Revenue by Type (2019-2030)
9.1.2 North America Low Molecular Weight Heparin Sales by Type (2019-2030)
9.1.3 North America Low Molecular Weight Heparin Price by Type (2019-2030)
9.2 North America Low Molecular Weight Heparin Market Size by Application
9.2.1 North America Low Molecular Weight Heparin Revenue by Application (2019-2030)
9.2.2 North America Low Molecular Weight Heparin Sales by Application (2019-2030)
9.2.3 North America Low Molecular Weight Heparin Price by Application (2019-2030)
9.3 North America Low Molecular Weight Heparin Market Size by Country
9.3.1 North America Low Molecular Weight Heparin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 North America Low Molecular Weight Heparin Sales by Country (2019 VS 2023 VS 2030)
9.3.3 North America Low Molecular Weight Heparin Price by Country (2019-2030)
9.3.4 U.S.
9.3.5 Canada
10 Europe
10.1 Europe Low Molecular Weight Heparin Market Size by Type
10.1.1 Europe Low Molecular Weight Heparin Revenue by Type (2019-2030)
10.1.2 Europe Low Molecular Weight Heparin Sales by Type (2019-2030)
10.1.3 Europe Low Molecular Weight Heparin Price by Type (2019-2030)
10.2 Europe Low Molecular Weight Heparin Market Size by Application
10.2.1 Europe Low Molecular Weight Heparin Revenue by Application (2019-2030)
10.2.2 Europe Low Molecular Weight Heparin Sales by Application (2019-2030)
10.2.3 Europe Low Molecular Weight Heparin Price by Application (2019-2030)
10.3 Europe Low Molecular Weight Heparin Market Size by Country
10.3.1 Europe Low Molecular Weight Heparin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
10.3.2 Europe Low Molecular Weight Heparin Sales by Country (2019 VS 2023 VS 2030)
10.3.3 Europe Low Molecular Weight Heparin Price by Country (2019-2030)
10.3.4 Germany
10.3.5 France
10.3.6 U.K.
10.3.7 Italy
10.3.8 Russia
11 China
11.1 China Low Molecular Weight Heparin Market Size by Type
11.1.1 China Low Molecular Weight Heparin Revenue by Type (2019-2030)
11.1.2 China Low Molecular Weight Heparin Sales by Type (2019-2030)
11.1.3 China Low Molecular Weight Heparin Price by Type (2019-2030)
11.2 China Low Molecular Weight Heparin Market Size by Application
11.2.1 China Low Molecular Weight Heparin Revenue by Application (2019-2030)
11.2.2 China Low Molecular Weight Heparin Sales by Application (2019-2030)
11.2.3 China Low Molecular Weight Heparin Price by Application (2019-2030)
12 Asia (Excluding China)
12.1 Asia Low Molecular Weight Heparin Market Size by Type
12.1.1 Asia Low Molecular Weight Heparin Revenue by Type (2019-2030)
12.1.2 Asia Low Molecular Weight Heparin Sales by Type (2019-2030)
12.1.3 Asia Low Molecular Weight Heparin Price by Type (2019-2030)
12.2 Asia Low Molecular Weight Heparin Market Size by Application
12.2.1 Asia Low Molecular Weight Heparin Revenue by Application (2019-2030)
12.2.2 Asia Low Molecular Weight Heparin Sales by Application (2019-2030)
12.2.3 Asia Low Molecular Weight Heparin Price by Application (2019-2030)
12.3 Asia Low Molecular Weight Heparin Market Size by Country
12.3.1 Asia Low Molecular Weight Heparin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 Asia Low Molecular Weight Heparin Sales by Country (2019 VS 2023 VS 2030)
12.3.3 Asia Low Molecular Weight Heparin Price by Country (2019-2030)
12.3.4 Japan
12.3.5 South Korea
12.3.6 India
12.3.7 Australia
12.3.8 China Taiwan
12.3.9 Southeast Asia
13 Middle East, Africa and Latin America
13.1 Middle East, Africa and Latin America Low Molecular Weight Heparin Market Size by Type
13.1.1 Middle East, Africa and Latin America Low Molecular Weight Heparin Revenue by Type (2019-2030)
13.1.2 Middle East, Africa and Latin America Low Molecular Weight Heparin Sales by Type (2019-2030)
13.1.3 Middle East, Africa and Latin America Low Molecular Weight Heparin Price by Type (2019-2030)
13.2 Middle East, Africa and Latin America Low Molecular Weight Heparin Market Size by Application
13.2.1 Middle East, Africa and Latin America Low Molecular Weight Heparin Revenue by Application (2019-2030)
13.2.2 Middle East, Africa and Latin America Low Molecular Weight Heparin Sales by Application (2019-2030)
13.2.3 Middle East, Africa and Latin America Low Molecular Weight Heparin Price by Application (2019-2030)
13.3 Middle East, Africa and Latin America Low Molecular Weight Heparin Market Size by Country
13.3.1 Middle East, Africa and Latin America Low Molecular Weight Heparin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
13.3.2 Middle East, Africa and Latin America Low Molecular Weight Heparin Sales by Country (2019 VS 2023 VS 2030)
13.3.3 Middle East, Africa and Latin America Low Molecular Weight Heparin Price by Country (2019-2030)
13.3.4 Mexico
13.3.5 Brazil
13.3.6 Israel
13.3.7 Argentina
13.3.8 Colombia
13.3.9 Turkey
13.3.10 Saudi Arabia
13.3.11 UAE
14 Value Chain and Sales Channels Analysis
14.1 Low Molecular Weight Heparin Value Chain Analysis
14.1.1 Low Molecular Weight Heparin Key Raw Materials
14.1.2 Raw Materials Key Suppliers
14.1.3 Manufacturing Cost Structure
14.1.4 Low Molecular Weight Heparin Production Mode & Process
14.2 Low Molecular Weight Heparin Sales Channels Analysis
14.2.1 Direct Comparison with Distribution Share
14.2.2 Low Molecular Weight Heparin Distributors
14.2.3 Low Molecular Weight Heparin Customers
15 Concluding Insights
16 Appendix
16.1 Reasons for Doing This Study
16.2 Research Methodology
16.3 Research Process
16.4 Authors List of This Report
16.5 Data Source
16.5.1 Secondary Sources
16.5.2 Primary Sources
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings